Belldegrun Arie (CIK 0001296549)

Latest company ownership

ALLO - Allogene Therapeutics, Inc.

Role: Director

Shares held

8,375,142

Last filed at

May 20, 2024

Confidence Score

50.0

2025Q4

Confidence Score History

2018Q4 2025Q4

LBRX - LB PHARMACEUTICALS INC

Role: 10% Owner

Shares held

1,434

Last filed at

Sep 10, 2025

Confidence Score

59.4

2025Q4

Confidence Score History

2025Q3 2025Q4

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Sep 12, 2025	Sep 16, 2025	LB PHARMACEUTICALS INC	10% Owner	Buy	100.0	+333,333	60.57%	✗	$5M
May 16, 2024	May 20, 2024	Allogene Therapeutics, Inc.	Director	Buy	100.0	+2,068,965	100.34%	✗	$5M
Jan 12, 2022	Jan 14, 2022	Allogene Therapeutics, Inc.	Director	Buy	100.0	+155,039	37.64%	✗	$2M
Jun 4, 2020	Jun 4, 2020	Allogene Therapeutics, Inc.	Director	Buy	96.3	+146,382	7.95%	✗	$6.9M
Oct 15, 2018	Feb 13, 2019	Allogene Therapeutics, Inc.	Director	Buy	100.0	+194,445	12.99%	✗	$3.5M
Oct 15, 2018	Oct 17, 2018	Allogene Therapeutics, Inc.	Director	Buy	92.5	+35,000	7.17%	✗	$630K